Saturday, November 22, 2014
Wednesday, November 19, 2014
When asked about the research findings to date, Mr. Guzman noted that "published research clearly shows the anticancer action of cannabinoids impacting glioblastoma multiforma (GBM), and how chemotherapy results of tumor reduction are improved upon by adding cannabinoids as part of the treatment regimen."
"We have an obligation to remain open minded about where the cure for brain cancer will come from, said Michael Klipper, Chairman of Voices Against Brain Cancer. Manuel Guzmán and his research team are world class leaders in the clinical research of cannabinoids and cancer." We recognize our responsibility to disseminate the information associated with the published research, which supports the medicinal legitimacy and can help guide patients and government lawmakers when considering the use of Cannabinoids."